Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

IND filed by Cell Pathways for new SAAND; lead compound Prevatac enters clinic for sixth indication

Dec. 30, 1998

Water-soluble anticancer compounds available for licensing from NIH

Dec. 30, 1998

Several NDAs up for review by FDA oncologic advisory committee in January

Dec. 30, 1998

Grant to help Faulding and collaborators develop innovative prostate cancer treatment

Dec. 29, 1998

Vion pursues prodrugs of 3-AP with superior biological, pharmaceutical properties

Dec. 29, 1998

Resveratrol shown to bind to and cleave DNA

Dec. 29, 1998

U.S. clinical trials of SU-6668 slated for early 1999

Dec. 29, 1998

Isis obtains antisense cancer rights from Genzyme Molecular Oncology

Dec. 28, 1998

First convincing data for extended therapeutic gene expression by human stem cells

Dec. 28, 1998

In vivo safety and efficacy of photodynamic therapy evaluated by Theratechnologies in CML patients

Dec. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...